Colchicine Levels in the Serum of FMF (Familial Mediterranean Fever) Patients

Sheba Medical Center80 enrolled

Overview

in this study the investigators will measure the colchicine trough levels in 80 FMF patients taking stable doses of colchicine

80 FMF patients will enroll: 20 taking 1 mg colchicine a day 20 taking 1.5 mg colchicine a day 20 taking 2 mg colchicine a day 20 taking 2.5 mg colchicine a day one blood sample for trough colchicine levels will be taken. response to treatment, colchicine side effects and anthropometric data will be collected.

Study Type

OBSERVATIONAL

Enrollment

Conditions

FMF Colchicine Resistance Colchicine Toxicity

Interventions

colchicine level measurementDIAGNOSTIC_TEST

levels of colchicine will be measured in FMF patients taking colchicine

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * constant colchicine levels

Locations (1)

Sheba Medical Center

Ramat Gan, Israel

RECRUITING

Outcomes

Primary Outcomes

colchicine levels

the trough level of colchicine in the serum

Time frame: a single measurement under a constant dosage at visit 1 (time=0, recruitment)

Central Contacts

merav lidar, prof

CONTACT

+972-3-5304413 merav.lidar@sheba.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.